Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37742322)

  • 1. Engineered Microbial Nanohybrids for Tumor-Mediated NIR II Photothermal Enhanced Ferroptosis/Cuproptosis and Immunotherapy.
    Ruan Y; Zhuang H; Zeng X; Lin L; Wang X; Xue P; Xu S; Chen Q; Yan S; Huang W
    Adv Healthc Mater; 2024 Feb; 13(4):e2302537. PubMed ID: 37742322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mild-Photothermal Effect Induced High Efficiency Ferroptosis-Boosted-Cuproptosis Based on Cu
    Chen W; Xie W; Gao Z; Lin C; Tan M; Zhang Y; Hou Z
    Adv Sci (Weinh); 2023 Nov; 10(33):e2303694. PubMed ID: 37822154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A biomimetic cuproptosis amplifier for targeted NIR-II fluorescence/photoacoustic imaging-guided synergistic NIR-II photothermal immunotherapy.
    Dai Y; Zhu L; Li X; Zhang F; Chen K; Jiao G; Liu Y; Yang Z; Guo Z; Zhang B; Shen Q; Zhao Q
    Biomaterials; 2024 Mar; 305():122455. PubMed ID: 38160626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-situ fabrication of novel Au nanoclusters-Cu
    Yang Z; Zhao Z; Cheng H; Shen Y; Xie A; Zhu M
    J Colloid Interface Sci; 2023 Jul; 641():215-228. PubMed ID: 36933468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonferrous Ferroptosis Inducer Manganese Molybdate Nanoparticles to Enhance Tumor Immunotherapy.
    Lei H; Li Q; Pei Z; Liu L; Yang N; Cheng L
    Small; 2023 Nov; 19(45):e2303438. PubMed ID: 37420331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy.
    Xiao Y; Zhu T; Zeng Q; Tan Q; Jiang G; Huang X
    Acta Biomater; 2023 Feb; 157():451-466. PubMed ID: 36442821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An active-passive strategy for enhanced synergistic photothermal-ferroptosis therapy in the NIR-I/II biowindows.
    Wu F; Chen H; Liu R; Suo Y; Li Q; Zhang Y; Liu H; Cheng Z; Chang Y
    Biomater Sci; 2022 Feb; 10(4):1104-1112. PubMed ID: 35044388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanocodelivery of an NIR photothermal agent and an acid-responsive TLR7 agonist prodrug to enhance cancer photothermal immunotherapy and the abscopal effect.
    Chen B; Huang R; Zeng W; Wang W; Min Y
    Biomaterials; 2024 Mar; 305():122434. PubMed ID: 38141501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. H
    Li Y; Chen W; Qi Y; Wang S; Li L; Li W; Xie T; Zhu H; Tang Z; Zhou M
    Small; 2020 Sep; 16(37):e2001356. PubMed ID: 32789963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of NIR therapy and regulatory T cell modulation using layer-by-layer hybrid nanoparticles for effective cancer photoimmunotherapy.
    Ou W; Jiang L; Thapa RK; Soe ZC; Poudel K; Chang JH; Ku SK; Choi HG; Yong CS; Kim JO
    Theranostics; 2018; 8(17):4574-4590. PubMed ID: 30279723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-Site Nanozymes with a Highly Conjugated Coordination Structure for Antitumor Immunotherapy via Cuproptosis and Cascade-Enhanced T Lymphocyte Activity.
    Liu Y; Niu R; Zhao H; Wang Y; Song S; Zhang H; Zhao Y
    J Am Chem Soc; 2024 Feb; 146(6):3675-3688. PubMed ID: 38305736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor microenvironment-responsive nanohybrid for hypoxia amelioration with photodynamic and near-infrared II photothermal combination therapy.
    Zhang P; Wu Q; Yang J; Hou M; Zheng B; Xu J; Chai Y; Xiong L; Zhang C
    Acta Biomater; 2022 Jul; 146():450-464. PubMed ID: 35526739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticles Synergize Ferroptosis and Cuproptosis to Potentiate Cancer Immunotherapy.
    Li Y; Liu J; Chen Y; Weichselbaum RR; Lin W
    Adv Sci (Weinh); 2024 Mar; ():e2310309. PubMed ID: 38477411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifunctional nanoparticles precisely reprogram the tumor microenvironment and potentiate antitumor immunotherapy after near-infrared-II light-mediated photothermal therapy.
    Ge Y; Zhang J; Jin K; Ye Z; Wang W; Zhou Z; Ye J
    Acta Biomater; 2023 Sep; 167():551-563. PubMed ID: 37302731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phototheranostic nanoparticles with aggregation-induced emission as a four-modal imaging platform for image-guided photothermal therapy and ferroptosis of tumor cells.
    Wang Z; Wang Y; Gao H; Tang C; Feng Z; Lin L; Che S; Luo C; Ding D; Zheng D; Yu Z; Peng Z
    Biomaterials; 2022 Oct; 289():121779. PubMed ID: 36099712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanin-Based Immunoregulatory Nanohybrids Enhance Antitumor Immune Responses in Breast Cancer Mouse Model.
    Guo K; Jiao Z; Zhao X; Hu Y; Zhao N; Xu FJ
    ACS Nano; 2023 Jun; 17(11):10792-10805. PubMed ID: 37265256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-delivery of metal-coordinated NIR-II nanoadjuvants for multimodal imaging-guided photothermal-chemodynamic amplified immunotherapy.
    Dai Y; Li X; Xue Y; Chen K; Jiao G; Zhu L; Li M; Fan Q; Dai Y; Zhao Q; Shen Q
    Acta Biomater; 2023 Aug; 166():496-511. PubMed ID: 37230439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationally designed dual-plasmonic gold nanorod@cuprous selenide hybrid heterostructures by regioselective overgrowth for
    Shan B; Wang H; Li L; Zhou G; Wen Y; Chen M; Li M
    Theranostics; 2020; 10(25):11656-11672. PubMed ID: 33052239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acidity-Activatable Dynamic Nanoparticles Boosting Ferroptotic Cell Death for Immunotherapy of Cancer.
    Song R; Li T; Ye J; Sun F; Hou B; Saeed M; Gao J; Wang Y; Zhu Q; Xu Z; Yu H
    Adv Mater; 2021 Aug; 33(31):e2101155. PubMed ID: 34170581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis.
    Hu S; Ma J; Su C; Chen Y; Shu Y; Qi Z; Zhang B; Shi G; Zhang Y; Zhang Y; Huang A; Kuang Y; Cheng P
    Acta Biomater; 2021 Nov; 135():567-581. PubMed ID: 34506976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.